A nurse is caring for a client with syndrome of inappropriate antidiuretic hormone secretion (SIADH). Which nursing intervention is the priority for this client?

SIADH causes excessive ADH secretion leading to water retention and dilutional hyponatremia. Fluid restriction is the primary treatment to correct the electrolyte imbalance and prevent cerebral edema.

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a condition where antidiuretic hormone (ADH) is excessively secreted from the posterior pituitary gland or ectopic sites. This increases water reabsorption in the kidneys, leading to water retention and dilutional hyponatremia.

Pathophysiologically, ADH binds to receptors in the kidney's collecting ducts, increasing water permeability and reabsorption. This dilutes the plasma and concentrates the urine, causing hyponatremia (serum sodium

Understanding the Priority: Client Safety and Cerebral Edema

This client presents with a classic picture of severe, symptomatic hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). The laboratory values are critical: a serum sodium of 118 mEq/L and serum osmolality of 265 mOsm/kg confirm a hypotonic state. The urine osmolality of 450 mOsm/kg is inappropriately concentrated, demonstrating that the kidneys are retaining water despite the body’s low osmolality—the hallmark of SIADH. The client's reports of headache, confusion, and nausea are not vague complaints; they are neurological manifestations of cerebral edema caused by the osmotic shift of water into brain cells. In the context of SIADH, where the primary problem is water retention due to excess ADH, the most immediate and definitive nursing action to halt the progression of hyponatremia and prevent life-threatening complications such as seizures or posterior reversible encephalopathy syndrome (PRES) is to restrict free water intake. As noted in the literature, severe hyponatremia from SIADH can lead to significant neurological deterioration, including encephalopathy and cerebral edema, making prompt correction of the underlying water excess a clinical priority [2, 3].

Analyzing the Incorrect Options

- Option 1: Encourage increased fluid intake to prevent dehydration. This action is contraindicated and dangerous. The client is not dehydrated; they are in a euvolemic state with water intoxication. Increasing fluid intake would further dilute the serum sodium, worsening the cerebral edema and neurological symptoms. The foundational principle of SIADH management is to reverse the dilutional hyponatremia by limiting water, not adding to it [1, 4].
- Option 2: Administer diuretics to increase urine output. While loop diuretics can be used as an adjunct therapy in some SIADH cases to promote free water excretion, this is not the first-line nursing action. Diuretic administration requires a specific order and is a pharmacological intervention that follows the initial, non-invasive step of fluid restriction. Furthermore, indiscriminate diuretic use could lead to overly rapid sodium correction or electrolyte imbalances. The priority is to immediately stop the intake that is causing the harm.
- Option 3: Monitor for signs of hypernatremia. This action reflects a misunderstanding of the pathophysiology. The client’s current state is profound hyponatremia. While monitoring is always a nursing responsibility, it is not the first action. The immediate concern is correcting the hyponatremia, not looking for a complication of its treatment that has not yet occurred. The priority is to implement the intervention that directly addresses the cause of the current symptoms.

The Rationale for Fluid Restriction as the First Action

The cornerstone of SIADH treatment is restricting free water intake. This directly counteracts the effect of excess ADH, which is causing the kidneys to reabsorb water inappropriately. By limiting fluid, you create a controlled state of negative water balance, allowing the serum sodium concentration to gradually rise as excess water is excreted. A randomized clinical trial on hyponatremia management identifies fluid restriction as the standard first-line therapy, even while acknowledging that pharmacological agents like tolvaptan may be used if restriction fails ^[4]. The case report on refractory hyponatremia in small cell lung cancer also reinforces that the initial management of SIADH-related hyponatremia centers on fluid restriction, alongside addressing the underlying malignancy ^[1]. For a nurse, implementing this order is the most direct and urgent step to prevent further neurological decline from a sodium level that is already critically low.

Clinical Practice Guide
The core of nursing care for SIADH patients is strict intake and output (I&O) measurement and daily weight monitoring. Weight changes are a sensitive indicator of fluid balance. If fluid restriction (e.g., 500-1000 mL/day) is ordered, educate on methods to relieve thirst with ice chips or oral care. Frequent assessment of neurological status (level of consciousness, headache, nausea) is essential.
Caution
In SATA (Select All That Apply) questions, for the question "What is an appropriate intervention for an SIADH patient?", "encouraging fluid intake" or "administering loop diuretics (furosemide)" are incorrect answers. Fluid intake worsens the condition, and diuretics can further excrete already low sodium. Demeclocycline (ADH antagonist) or vaptans (receptor antagonists) are sometimes used for SIADH.